CompletedPhase 3NCT02374060
PeriOcular and INTravitreal Corticosteroids for Uveitic Macular Edema Trial
Studying Uveitis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- JHSPH Center for Clinical Trials
- Principal Investigator
- Douglas A Jabs, MD, MBAIcahn School of Medicine, Noutn Sinai, New York, NY
- Intervention
- Periocular triamcinolone 40 mg(drug)
- Enrollment
- 192 target
- Eligibility
- 18 years · All sexes
- Timeline
- 2015 – 2018
Study locations (26)
- Jules Stein Eye Institute, UCLA, Los Angeles, California, United States
- University of California, San Francisco, San Francisco, California, United States
- Anne Bates Leach Eye Hospital, University of Miami Miller School of Medicine, Miami, Florida, United States
- University of South Florida, Tampa, Florida, United States
- Emory University, Atlanta, Georgia, United States
- Northwestern University, Chicago, Illinois, United States
- Rush University Medical Center, Chicago, Illinois, United States
- University of Iowa, Iowa City, Iowa, United States
- Johns Hopkins University, Baltimore, Maryland, United States
- National Eye Institute, NIH, Bethesda, Maryland, United States
- Massachusetts Eye and Ear Infirmary, Boston, Massachusetts, United States
- Ophthalmic Consultants of Boston, Boston, Massachusetts, United States
- Kellogg Eye Center, University of Michigan, Ann Arbor, Michigan, United States
- MAYO Clinic, Rochester, Minnesota, United States
- Washington University School of Medicine, St Louis, Missouri, United States
- +11 more locations on ClinicalTrials.gov
Collaborators
National Eye Institute (NEI)
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT02374060 on ClinicalTrials.govOther trials for Uveitis
Additional recruiting or active studies for the same condition.
- RECRUITINGNCT06974162Metagenomics for Ocular InflammationMoorfields Eye Hospital NHS Foundation Trust
- ACTIVE NOT RECRUITINGNCT06821971Study of Risk Factors for Therapeutic Failure in Chronic Non-Infectious Uveitis After First-Line Immunosuppressive TherapyCentre Hospitalier Universitaire, Amiens
- RECRUITINGEARLY PHASE1NCT07145008Suprachoroidal Triamcinolone in Macular Edema for Patients With Non-Infectious Uveitis Resistant to Subtenon TriamcinolonUniversity of Baghdad
- ACTIVE NOT RECRUITINGNANCT06585670Mindfulness Approach for Reducing Anxiety and Gloom in Ocular Inflammatory DiseasesUniversity of California, San Francisco
- RECRUITINGPHASE1NCT06161415Safety, Tolerability, and Distribution of Laquinimod Eye Drops : The LION StudyQuan Dong Nguyen
- ACTIVE NOT RECRUITINGNCT06686641Incidence of Macular Edema in a Uveitis PopulationAalborg University Hospital
- ACTIVE NOT RECRUITINGNANCT06310837Effect of Immunosuppressants With Adalimumab Biosimilars vs Corticosteroids on Noninfectious UveitisZhongshan Ophthalmic Center, Sun Yat-sen University
- RECRUITINGNCT05727540The Cohort Study of Uveitis PatientsZhongshan Ophthalmic Center, Sun Yat-sen University